☆ 4.6 Article

Safety and immunogenicity of a QazCovid-in® inactivated whole-virion vaccine against COVID-19 in healthy adults: A single-centre, randomised, single-blind, placebo-controlled phase 1 and an open-label phase 2 clinical trials with a 6 months follow-up in Kazakhstan

ECLINICALMEDICINE (2021)

Related references

Note: Only part of the references are listed.

Article Infectious Diseases

A whole blood test to measure SARS-CoV-2-specific response in COVID-19 patients

Linda Petrone et al.

Summary: The study showed that specific T cell responses to SARS CoV 2 peptides can be detected in COVID-19 patients and are significantly different from individuals without COVID-19. This immune response exhibits characteristics of both Th1 and Th2 profiles, potentially serving as a new T cell-based diagnostic tool.

CLINICAL MICROBIOLOGY AND INFECTION (2021)

Add to Collection

Article Infectious Diseases

Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: a randomised, double-blind, placebo-controlled, phase 1/2 trial

Shengli Xia et al.

Summary: The inactivated SARS-CoV-2 vaccine, BBIBP-CorV, demonstrated safety and immunogenicity in two age groups. Humoral responses against SARS-CoV-2 were induced in all vaccine recipients by day 42. A two-dose immunisation with 4 mu g vaccine on days 0 and 21 or days 0 and 28 achieved higher neutralising antibody titres compared to other dosing schedules.

LANCET INFECTIOUS DISEASES (2021)

Add to Collection

Article Medicine, General & Internal

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK

Merryn Voysey et al.

Summary: The ChAdOx1 nCoV-19 vaccine has been shown to have an acceptable safety profile and effectiveness against symptomatic COVID-19, with higher efficacy observed in the group that received a low dose followed by a standard dose.

LANCET (2021)

Add to Collection

Review Medicine, General & Internal

Maintaining Safety with SARS-CoV-2 Vaccines

Mariana C. Castells et al.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Add to Collection

Article Multidisciplinary Sciences

Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection

Jennifer M. Dan et al.

Summary: Different components of immune memory to SARS-CoV-2 exhibit distinct kinetics, with antibodies and spike-specific memory B cells remaining relatively stable over 6 months, while CD4(+) T cells and CD8(+) T cells declining with a half-life of 3 to 5 months after infection.

SCIENCE (2021)

Add to Collection

Letter Medicine, General & Internal

Acute Allergic Reactions to mRNA COVID-19 Vaccines

Kimberly G. Blumenthal et al.

Summary: This study investigates the occurrence of acute allergic reactions to mRNA COVID-19 vaccines among healthcare employees in Massachusetts.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)

Add to Collection

Article Infectious Diseases

Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18-59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial

Yanjun Zhang et al.

Summary: This study investigated the safety, tolerability, and immunogenicity of the COVID-19 vaccine candidate CoronaVac, and found that the 3 μg dose showed higher seroconversion rates in the phase 2 trial.

LANCET INFECTIOUS DISEASES (2021)

Add to Collection

Article Infectious Diseases

COVID-19 case fatality risk by age and gender in a high testing setting in Latin America: Chile, March-August 2020

Eduardo A. Undurraga et al.

Summary: Early severity estimates of COVID-19 are crucial for assessing the impact of the pandemic. In Chile, real-time delay-adjusted case fatality rates show higher impact on male seniors, especially those aged 70 and above. The peak in estimated CFR during the epidemic peak may be due to insufficient laboratory capacity leading to lower reporting rates.

INFECTIOUS DISEASES OF POVERTY (2021)

Add to Collection

Editorial Material Medicine, General & Internal

Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention

Zunyou Wu et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

Add to Collection

Review Medicine, General & Internal

Prevalence of Asymptomatic SARS-CoV-2 Infection A Narrative Review

Daniel P. Oran et al.

ANNALS OF INTERNAL MEDICINE (2020)

Add to Collection

Article Medicine, General & Internal

Effect of an Inactivated Vaccine Against SARS-CoV-2 on Safety and Immunogenicity Outcomes Interim Analysis of 2 Randomized Clinical Trials

Shengli Xia et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

Add to Collection

Article Medicine, General & Internal

Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial

Feng-Cai Zhu et al.

LANCET (2020)

Add to Collection

Article Medicine, General & Internal

Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial

Pedro M. Folegatti et al.

LANCET (2020)

Add to Collection

Article Medicine, General & Internal

An mRNA Vaccine against SARS-CoV-2-Preliminary Report

L. A. Jackson et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Add to Collection

Article Medicine, General & Internal

Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia

Denis Y. Logunov et al.

LANCET (2020)

Add to Collection

Article Multidisciplinary Sciences

Design of novel multiepitope constructs-based peptide vaccine against the structural S, N and M proteins of human COVID-19 using immunoinformatics analysis

Niloofar Khairkhah et al.

PLOS ONE (2020)

Add to Collection

Review Immunology

IL-6 as a keystone cytokine in health and disease

Christopher A. Hunter et al.

NATURE IMMUNOLOGY (2015)

Add to Collection

© Peeref 2019-2024. All rights reserved.